You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pazopanib

Showing 1 - 25 of 335
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft Tissue Sarcoma Trial (pembrolizumab, pazopanib)

Not yet recruiting
  • Soft Tissue Sarcoma
  • pembrolizumab, pazopanib
  • (no location specified)
Dec 26, 2022

Solid Tumor Trial in Jacksonville, Rochester (Laboratory Biomarker Analysis, Pazopanib Hydrochloride, Pharmacological Study)

Active, not recruiting
  • Solid Neoplasm
  • Laboratory Biomarker Analysis
  • +2 more
  • Jacksonville, Florida
  • +1 more
Jan 25, 2023

Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

Active, not recruiting
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Refractory Solid Tumors Trial in Seoul (pazopanib)

Completed
  • Refractory Solid Tumors
  • pazopanib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 13, 2023

Hereditary Hemorrhagic Telangiectasia, Epistaxis, Anemia Trial (Pazopanib, Placebo oral capsule)

Not yet recruiting
  • Hereditary Hemorrhagic Telangiectasia
  • +4 more
  • Pazopanib
  • Placebo oral capsule
  • (no location specified)
Aug 17, 2022

Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle

Recruiting
  • Advanced Soft Tissue Sarcoma
  • +2 more
  • Nanoparticle Albumin-Bound Rapamycin
  • Pazopanib hydrochloride
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Refractory Solid Tumors Trial in Seoul (pazopanib)

Completed
  • Refractory Solid Tumors
  • pazopanib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States (drug,

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • pazopanib hydrochloride
  • +4 more
  • Chicago, Illinois
  • +4 more
Jul 26, 2022

Glioblastoma Multiforme Trial in Nice (Pazopanib)

Active, not recruiting
  • Glioblastoma Multiforme
  • Pazopanib
  • Nice, Cedex 2, France
    Centre Antoine Lacassagne
Mar 3, 2022

Solid Tumors Trial in Canada (Topotecan and Pazopanib)

Completed
  • Solid Tumors
  • Topotecan and Pazopanib
  • Calgary, Alberta, Canada
  • +9 more
Jun 27, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bordeaux, France
  • +4 more
May 5, 2022

Refractory or Recurrent Solid Tumor Trial in France (Spartalizumab in Pediatric cohort, Low-dose Pazopanib in Pediatric Cohort,

Not yet recruiting
  • Refractory or Recurrent Solid Tumor
  • Spartalizumab in Pediatric cohort
  • +3 more
  • Angers, France
  • +8 more
Mar 9, 2022

Advanced Cancers Trial in Houston (Crizotinib (Xalkori), Pazopanib, Pemetrexed)

Terminated
  • Advanced Cancers
  • Crizotinib (Xalkori)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 3, 2021

Sarcoma Trial in France (Nivolumab and IPILIMUMAB, Pazopanib Oral Tablet [Votrient])

Recruiting
  • Sarcoma
  • Nivolumab and IPILIMUMAB
  • Pazopanib Oral Tablet [Votrient]
  • Lyon, Rhône, France
  • +10 more
Jun 22, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial in United

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • Ascorbic Acid
  • Pazopanib Hydrochloride
  • Peoria, Illinois
  • +4 more
Mar 18, 2022

Solitary Fibrous Tumor, Extraskeletal Myxoid Chondrosarcoma Trial in Spain (Pazopanib)

Active, not recruiting
  • Solitary Fibrous Tumor
  • Extraskeletal Myxoid Chondrosarcoma
  • Pazopanib
  • Palma De Mallorca, Islas Baleares, Spain
  • +6 more
Jan 31, 2022

Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)

Completed
Has Results
  • Kidney Cancer
  • Pazopanib
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 24, 2021

Advanced Renal Cell Carcinoma Trial in Spain (Pazopanib + interferon alpha 2A)

Completed
  • Advanced Renal Cell Carcinoma
  • Pazopanib + interferon alpha 2A
  • Hospitalet de Llobregat, Barcelona, Spain
  • +12 more
Mar 9, 2022

Renal Cell Carcinoma Trial in Ireland, Sweden (Pazopanib)

Completed
  • Renal Cell Carcinoma
  • Pazopanib
  • Dublin, Leinster, Ireland
  • +8 more
Dec 22, 2021

Unspecified Adult Solid Tumor - Protocol Specific, Breast Cancer - Female Trial in New Brunswick (Pazopanib, Paclitaxel,

Active, not recruiting
  • Unspecified Adult Solid Tumor - Protocol Specific
  • Breast Cancer - Female
  • Pazopanib
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma Trial in United States (Pazopanib, Doxil)

Terminated
Has Results
  • Ovarian Cancer
  • +2 more
  • Fort Myers, Florida
  • +3 more
Oct 4, 2021

Angiosarcoma Trial in Austria, Germany (Pazopanib + Paclitaxel)

Terminated
Has Results
  • Angiosarcoma
  • Pazopanib + Paclitaxel
  • Graz, Austria
  • +9 more
Jan 21, 2022

Metastatic Solid Tumors Trial in San Francisco (PZP115891, PCI-24781)

Recruiting
  • Metastatic Solid Tumors
  • PZP115891, PCI-24781
  • San Francisco, California
    University of California, San Francisco
Aug 23, 2021

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
Has Results
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021